J. Jaime
- Hematology top 0.1%
- Erythropoietin and Anemia Treatment 45
- Iron Metabolism and Disorders 17
- Family Practice top 0.2%
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism 38
- Geriatrics and Gerontology top 0.5%
- Genetics top 0.5%
- Hemoglobinopathies and Related Disorders 28
-
- Health Systems, Economic Evaluations, Quality of Life 77
- Pharmaceutical Economics and Policy 24
-
- Erythrocyte Function and Pathophysiology 22
-
- Metabolism, Diabetes, and Cancer 18
- Co-authors
- Susana Alicia SalcedaSimon DagenaisScott HaldemanMaribel SalasJudith A. O’BrienKrista F. HuybrechtsО. H. MinchenkoK. Jack Ishak
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
J. Jaime
368 papers receiving 23.1k citations
Hit Papers
Peers
Comparison fields: 5 of 199
- Hematology 3.4k
- Family Practice 668
- Cancer Research 4.2k
- Geriatrics and Gerontology 719
- Genetics 1.6k
Countries citing papers authored by J. Jaime
This map shows the geographic impact of J. Jaime's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jaime with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jaime more than expected).
Fields of papers citing papers by J. Jaime
This network shows the impact of papers produced by J. Jaime. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jaime. The network helps show where J. Jaime may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J. Jaime, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 25 | |
| 5 | 2021 | 1 | |
| 6 | Effect of a comprehensive ambulatory care model on outcomes of patients with acute coronary syndrome in Colombia. | 2015 | 2 |
| 7 | 2013 | 1 | |
| 8 | Los modelos de simulación de eventos discretos en la evaluación económica de tecnologías y productos sanitarios | 2008 | 5 |
| 9 | 2008 | 68 | |
| 10 | Descriptive Analysis of the Process and Quality of Oral Anticoagulation Management in Real-Life Practice in Patients with Chronic Non-valvular Atrial Fibrillation | 2007 | 2 |
| 11 | 2006 | 219 | |
| 12 | 2005 | 36 | |
| 13 | 2005 | 20 | |
| 14 | 2004 | 6 | |
| 15 | Cefepime-metronidazol versus cefotaxima-metronidazol en infecciones intraabdominales. Estudio farmacoeconómico | 2003 | 1 |
| 16 | 2001 | 59 | |
| 17 | 1999 | 102 | |
| 18 | 1999 | 2 | |
| 19 | The cost-effectiveness of preventing initial coronary events with pravastatin | 1997 | 3 |
| 20 | 1993 | 27 |
About J. Jaime
J. Jaime is a scholar working on Family Practice, Hematology and Geriatrics and Gerontology, having authored 383 papers that have together received 24.1k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (77 papers), Erythropoietin and Anemia Treatment (45 papers), Cancer, Hypoxia, and Metabolism (38 papers), Hemoglobinopathies and Related Disorders (28 papers), Pharmaceutical Economics and Policy (24 papers), Erythrocyte Function and Pathophysiology (22 papers), Metabolism, Diabetes, and Cancer (18 papers) and Iron Metabolism and Disorders (17 papers). The work is most often cited by research in Hematology (3.4k citations), Family Practice (668 citations) and Cancer Research (4.2k citations). J. Jaime has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Susana Alicia Salceda, Simon Dagenais, Scott Haldeman, Maribel Salas, Judith A. O’Brien, Krista F. Huybrechts, О. H. Minchenko, K. Jack Ishak, Glenwood Goss and Alexandra M. Ward. Their work appears in journals such as Value in Health, PharmacoEconomics, Blood, Clinical Therapeutics and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.